Global Steroids - Market

Steroids - Comprehensive Study by Type (Tablets, Syrups, Inhaler, Nasal Spray, Injection, Cream/ Gel), Application (Asthma, Hay Fever, Painful Joints or Muscles, Chronic Obstructive Pulmonary Disease, Inflammatory Bowel Disease, Others), End Users (Hospital, Patient, Body Builder, Gymnastics, Others), Distribution Channel (Pharmacy, Hospital, Clinic, Online, Others), Species Types (Fungal Steroid, Plant Steroid, Animal Steroid, Others) Players and Region - Global Market Outlook to 2027

Steroids - Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Steroids -
A steroid is an organic compound that is biologically active and has four rings arranged in a specific molecular configuration. Steroids serve two primary biological functions: they are important components of cell membranes that change membrane fluidity and they act as signaling molecules. Steroids, also known as corticosteroids, are anti-inflammatory medications that are used to treat a variety of conditions. Steroids are synthetic versions of hormones that are normally produced by the adrenal glands, which are two small glands above the kidneys. Steroids also suppress the immune system's activity, which is the body's natural defense against illness and infection. Any of a class of lipids (fats) with a specific chemical structure. Steroids can be found naturally in plants and animals or synthesized in the laboratory. Steroids include sex hormones, cholesterol, bile acids, and certain drugs

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


There is less competition on the global market for steroids because there are more players and more services being offered. To increase their revenue and growth in the global steroid market, the companies follow new product launches or innovations. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Steroids - market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Pfizer (United States), Sanofi-Aventis (France), GlaxoSmithKline (United Kingdom), Novartis (Switzerland), AstraZeneca (United Kingdom), Merck (United States), Johnson & Johnson (United States), Roche (Switzerland), Eli Lilly & Co (United States) and Bristol-Myers Squibb (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Wyeth (United States), Schering-Plough (United States) and Abbott Laboratories (United States).

Segmentation Overview
AMA Research has segmented the market of Global Steroids - market by Type (Tablets, Syrups, Inhaler, Nasal Spray, Injection and Cream/ Gel), Application (Asthma, Hay Fever, Painful Joints or Muscles, Chronic Obstructive Pulmonary Disease, Inflammatory Bowel Disease and Others) and Region.



On the basis of geography, the market of Steroids - has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Hospital will boost the Steroids - market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Pharmacy will boost the Steroids - market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Species Types , the sub-segment i.e. Fungal Steroid will boost the Steroids - market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2021 Merck to Acquire Acceleron Pharma Inc. Acceleron is focused on harnessing the power of the TGF-beta superfamily of proteins, which is known to play an important role in the regulation of cell growth, differentiation, and repair. Sotatercept, Accelerons lead therapeutic candidate, has a novel mechanism of action that has the potential to improve short-term and/or long-term clinical outcomes in pulmonary arterial hypertension patients. According to the terms of the acquisition agreement, Merck will launch a tender offer to acquire all outstanding Acceleron shares through a subsidiary.
On 2 May 2022 Plant-based anabolic complex launched to provide healthier steroid option. Nature Gains has released an entirely plant-based steroid combination supplement derived from plant testosterone boosters. The Natural Anabolic Complex in the NatuRoids product line aims to boost overall athletic performance. Ecdysterone, turkerstone, epicatechin, and Fadogia agrestis are the active ingredients. These mimic a chemically developed steroid for enhanced performance results when combined. It is the first time that this combination of plant-based steroid ecdysterone, turkesterone, and testosterone boosters is available to consumers as a dietary supplement
The Central Government proposed to make amendments to certain Drugs and Cosmetics Rules, in exercise of the powers conferred to it, by section 12 and section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), in consultation with the Drugs Technical Advisory Board. The adverse effects induced by rampant misuse of creams containing corticosteroids along with antibiotics and antifungals causing damage to the skin of Indian citizens. Increasing number of cases of Topical Steroid Damaged Face (TSDF) and steroid modified recalcitrant and/or extensive tinea (fungal infection of the skin known as ringworm) have come to the notice of the dermatologists. These creams are purchased and used by the patients without any doctor's prescription as Schedule H provided exemption for topical or external use preparations from the purview of Schedule H and H1, in the note appended to these Schedules

Market Drivers
  • Increase in Fatness Rates
  • The Growing Popularity of Steroids in Bodybuilding Sector

Opportunities
  • Bodybuilding Is Gaining Popularity among Young People
  • Mounting Focus Youngster on Enlarged Muscle Strength and Power

Restraints
  • Steroids Roots Sudden Mood Swings
  • Steroids Causes Heart Issues
  • Steroids Effect on Reproductive Issues

Challenges
  • Side Effect of Steroid Causes Difficulty of Slipping
  • Surges Risk of Blood Clots
  • Upsurge Threat of Kidney Failure or Liver Failure


Key Target Audience
Steroids manufacturer, Steroids Providers, Hospital, Household, Pharma Industry, Government Bodies, Corporate Entities and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Tablets
  • Syrups
  • Inhaler
  • Nasal Spray
  • Injection
  • Cream/ Gel
By Application
  • Asthma
  • Hay Fever
  • Painful Joints or Muscles
  • Chronic Obstructive Pulmonary Disease
  • Inflammatory Bowel Disease
  • Others
By End Users
  • Hospital
  • Patient
  • Body Builder
  • Gymnastics
  • Others

By Distribution Channel
  • Pharmacy
  • Hospital
  • Clinic
  • Online
  • Others

By Species Types
  • Fungal Steroid
  • Plant Steroid
  • Animal Steroid
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Fatness Rates
      • 3.2.2. The Growing Popularity of Steroids in Bodybuilding Sector
    • 3.3. Market Challenges
      • 3.3.1. Side Effect of Steroid Causes Difficulty of Slipping
      • 3.3.2. Surges Risk of Blood Clots
      • 3.3.3. Upsurge Threat of Kidney Failure or Liver Failure
    • 3.4. Market Trends
      • 3.4.1. High Adoption of Steroid in Body Building Sector
      • 3.4.2. Steroids Boost Protein Synthesis for Rises in Muscular Tissue
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Steroids -, by Type, Application, End Users, Distribution Channel, Species Types and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Steroids - (Value)
      • 5.2.1. Global Steroids - by: Type (Value)
        • 5.2.1.1. Tablets
        • 5.2.1.2. Syrups
        • 5.2.1.3. Inhaler
        • 5.2.1.4. Nasal Spray
        • 5.2.1.5. Injection
        • 5.2.1.6. Cream/ Gel
      • 5.2.2. Global Steroids - by: Application (Value)
        • 5.2.2.1. Asthma
        • 5.2.2.2. Hay Fever
        • 5.2.2.3. Painful Joints or Muscles
        • 5.2.2.4. Chronic Obstructive Pulmonary Disease
        • 5.2.2.5. Inflammatory Bowel Disease
        • 5.2.2.6. Others
      • 5.2.3. Global Steroids - by: End Users (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Patient
        • 5.2.3.3. Body Builder
        • 5.2.3.4. Gymnastics
        • 5.2.3.5. Others
      • 5.2.4. Global Steroids - by: Distribution Channel (Value)
        • 5.2.4.1. Pharmacy
        • 5.2.4.2. Hospital
        • 5.2.4.3. Clinic
        • 5.2.4.4. Online
        • 5.2.4.5. Others
      • 5.2.5. Global Steroids - Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Steroids - (Price)
      • 5.3.1. Global Steroids - by: Type (Price)
  • 6. Steroids -: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi-Aventis (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Johnson & Johnson (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Roche (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly & Co (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bristol-Myers Squibb (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Steroids - Sale, by Type, Application, End Users, Distribution Channel, Species Types and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Steroids - (Value)
      • 7.2.1. Global Steroids - by: Type (Value)
        • 7.2.1.1. Tablets
        • 7.2.1.2. Syrups
        • 7.2.1.3. Inhaler
        • 7.2.1.4. Nasal Spray
        • 7.2.1.5. Injection
        • 7.2.1.6. Cream/ Gel
      • 7.2.2. Global Steroids - by: Application (Value)
        • 7.2.2.1. Asthma
        • 7.2.2.2. Hay Fever
        • 7.2.2.3. Painful Joints or Muscles
        • 7.2.2.4. Chronic Obstructive Pulmonary Disease
        • 7.2.2.5. Inflammatory Bowel Disease
        • 7.2.2.6. Others
      • 7.2.3. Global Steroids - by: End Users (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Patient
        • 7.2.3.3. Body Builder
        • 7.2.3.4. Gymnastics
        • 7.2.3.5. Others
      • 7.2.4. Global Steroids - by: Distribution Channel (Value)
        • 7.2.4.1. Pharmacy
        • 7.2.4.2. Hospital
        • 7.2.4.3. Clinic
        • 7.2.4.4. Online
        • 7.2.4.5. Others
      • 7.2.5. Global Steroids - Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Steroids - (Price)
      • 7.3.1. Global Steroids - by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Steroids -: by Type(USD Million)
  • Table 2. Steroids - Tablets , by Region USD Million (2016-2021)
  • Table 3. Steroids - Syrups , by Region USD Million (2016-2021)
  • Table 4. Steroids - Inhaler , by Region USD Million (2016-2021)
  • Table 5. Steroids - Nasal Spray , by Region USD Million (2016-2021)
  • Table 6. Steroids - Injection , by Region USD Million (2016-2021)
  • Table 7. Steroids - Cream/ Gel , by Region USD Million (2016-2021)
  • Table 8. Steroids -: by Application(USD Million)
  • Table 9. Steroids - Asthma , by Region USD Million (2016-2021)
  • Table 10. Steroids - Hay Fever , by Region USD Million (2016-2021)
  • Table 11. Steroids - Painful Joints or Muscles , by Region USD Million (2016-2021)
  • Table 12. Steroids - Chronic Obstructive Pulmonary Disease , by Region USD Million (2016-2021)
  • Table 13. Steroids - Inflammatory Bowel Disease , by Region USD Million (2016-2021)
  • Table 14. Steroids - Others , by Region USD Million (2016-2021)
  • Table 15. Steroids -: by End Users(USD Million)
  • Table 16. Steroids - Hospital , by Region USD Million (2016-2021)
  • Table 17. Steroids - Patient , by Region USD Million (2016-2021)
  • Table 18. Steroids - Body Builder , by Region USD Million (2016-2021)
  • Table 19. Steroids - Gymnastics , by Region USD Million (2016-2021)
  • Table 20. Steroids - Others , by Region USD Million (2016-2021)
  • Table 21. Steroids -: by Distribution Channel(USD Million)
  • Table 22. Steroids - Pharmacy , by Region USD Million (2016-2021)
  • Table 23. Steroids - Hospital , by Region USD Million (2016-2021)
  • Table 24. Steroids - Clinic , by Region USD Million (2016-2021)
  • Table 25. Steroids - Online , by Region USD Million (2016-2021)
  • Table 26. Steroids - Others , by Region USD Million (2016-2021)
  • Table 27. South America Steroids -, by Country USD Million (2016-2021)
  • Table 28. South America Steroids -, by Type USD Million (2016-2021)
  • Table 29. South America Steroids -, by Application USD Million (2016-2021)
  • Table 30. South America Steroids -, by End Users USD Million (2016-2021)
  • Table 31. South America Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 32. South America Steroids -, by Species Types USD Million (2016-2021)
  • Table 33. Brazil Steroids -, by Type USD Million (2016-2021)
  • Table 34. Brazil Steroids -, by Application USD Million (2016-2021)
  • Table 35. Brazil Steroids -, by End Users USD Million (2016-2021)
  • Table 36. Brazil Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 37. Brazil Steroids -, by Species Types USD Million (2016-2021)
  • Table 38. Argentina Steroids -, by Type USD Million (2016-2021)
  • Table 39. Argentina Steroids -, by Application USD Million (2016-2021)
  • Table 40. Argentina Steroids -, by End Users USD Million (2016-2021)
  • Table 41. Argentina Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 42. Argentina Steroids -, by Species Types USD Million (2016-2021)
  • Table 43. Rest of South America Steroids -, by Type USD Million (2016-2021)
  • Table 44. Rest of South America Steroids -, by Application USD Million (2016-2021)
  • Table 45. Rest of South America Steroids -, by End Users USD Million (2016-2021)
  • Table 46. Rest of South America Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 47. Rest of South America Steroids -, by Species Types USD Million (2016-2021)
  • Table 48. Asia Pacific Steroids -, by Country USD Million (2016-2021)
  • Table 49. Asia Pacific Steroids -, by Type USD Million (2016-2021)
  • Table 50. Asia Pacific Steroids -, by Application USD Million (2016-2021)
  • Table 51. Asia Pacific Steroids -, by End Users USD Million (2016-2021)
  • Table 52. Asia Pacific Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 53. Asia Pacific Steroids -, by Species Types USD Million (2016-2021)
  • Table 54. China Steroids -, by Type USD Million (2016-2021)
  • Table 55. China Steroids -, by Application USD Million (2016-2021)
  • Table 56. China Steroids -, by End Users USD Million (2016-2021)
  • Table 57. China Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 58. China Steroids -, by Species Types USD Million (2016-2021)
  • Table 59. Japan Steroids -, by Type USD Million (2016-2021)
  • Table 60. Japan Steroids -, by Application USD Million (2016-2021)
  • Table 61. Japan Steroids -, by End Users USD Million (2016-2021)
  • Table 62. Japan Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 63. Japan Steroids -, by Species Types USD Million (2016-2021)
  • Table 64. India Steroids -, by Type USD Million (2016-2021)
  • Table 65. India Steroids -, by Application USD Million (2016-2021)
  • Table 66. India Steroids -, by End Users USD Million (2016-2021)
  • Table 67. India Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 68. India Steroids -, by Species Types USD Million (2016-2021)
  • Table 69. South Korea Steroids -, by Type USD Million (2016-2021)
  • Table 70. South Korea Steroids -, by Application USD Million (2016-2021)
  • Table 71. South Korea Steroids -, by End Users USD Million (2016-2021)
  • Table 72. South Korea Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 73. South Korea Steroids -, by Species Types USD Million (2016-2021)
  • Table 74. Australia Steroids -, by Type USD Million (2016-2021)
  • Table 75. Australia Steroids -, by Application USD Million (2016-2021)
  • Table 76. Australia Steroids -, by End Users USD Million (2016-2021)
  • Table 77. Australia Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 78. Australia Steroids -, by Species Types USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific Steroids -, by Type USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Steroids -, by Application USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Steroids -, by End Users USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Steroids -, by Species Types USD Million (2016-2021)
  • Table 84. Europe Steroids -, by Country USD Million (2016-2021)
  • Table 85. Europe Steroids -, by Type USD Million (2016-2021)
  • Table 86. Europe Steroids -, by Application USD Million (2016-2021)
  • Table 87. Europe Steroids -, by End Users USD Million (2016-2021)
  • Table 88. Europe Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 89. Europe Steroids -, by Species Types USD Million (2016-2021)
  • Table 90. Germany Steroids -, by Type USD Million (2016-2021)
  • Table 91. Germany Steroids -, by Application USD Million (2016-2021)
  • Table 92. Germany Steroids -, by End Users USD Million (2016-2021)
  • Table 93. Germany Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 94. Germany Steroids -, by Species Types USD Million (2016-2021)
  • Table 95. France Steroids -, by Type USD Million (2016-2021)
  • Table 96. France Steroids -, by Application USD Million (2016-2021)
  • Table 97. France Steroids -, by End Users USD Million (2016-2021)
  • Table 98. France Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 99. France Steroids -, by Species Types USD Million (2016-2021)
  • Table 100. Italy Steroids -, by Type USD Million (2016-2021)
  • Table 101. Italy Steroids -, by Application USD Million (2016-2021)
  • Table 102. Italy Steroids -, by End Users USD Million (2016-2021)
  • Table 103. Italy Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 104. Italy Steroids -, by Species Types USD Million (2016-2021)
  • Table 105. United Kingdom Steroids -, by Type USD Million (2016-2021)
  • Table 106. United Kingdom Steroids -, by Application USD Million (2016-2021)
  • Table 107. United Kingdom Steroids -, by End Users USD Million (2016-2021)
  • Table 108. United Kingdom Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 109. United Kingdom Steroids -, by Species Types USD Million (2016-2021)
  • Table 110. Netherlands Steroids -, by Type USD Million (2016-2021)
  • Table 111. Netherlands Steroids -, by Application USD Million (2016-2021)
  • Table 112. Netherlands Steroids -, by End Users USD Million (2016-2021)
  • Table 113. Netherlands Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 114. Netherlands Steroids -, by Species Types USD Million (2016-2021)
  • Table 115. Rest of Europe Steroids -, by Type USD Million (2016-2021)
  • Table 116. Rest of Europe Steroids -, by Application USD Million (2016-2021)
  • Table 117. Rest of Europe Steroids -, by End Users USD Million (2016-2021)
  • Table 118. Rest of Europe Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 119. Rest of Europe Steroids -, by Species Types USD Million (2016-2021)
  • Table 120. MEA Steroids -, by Country USD Million (2016-2021)
  • Table 121. MEA Steroids -, by Type USD Million (2016-2021)
  • Table 122. MEA Steroids -, by Application USD Million (2016-2021)
  • Table 123. MEA Steroids -, by End Users USD Million (2016-2021)
  • Table 124. MEA Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 125. MEA Steroids -, by Species Types USD Million (2016-2021)
  • Table 126. Middle East Steroids -, by Type USD Million (2016-2021)
  • Table 127. Middle East Steroids -, by Application USD Million (2016-2021)
  • Table 128. Middle East Steroids -, by End Users USD Million (2016-2021)
  • Table 129. Middle East Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 130. Middle East Steroids -, by Species Types USD Million (2016-2021)
  • Table 131. Africa Steroids -, by Type USD Million (2016-2021)
  • Table 132. Africa Steroids -, by Application USD Million (2016-2021)
  • Table 133. Africa Steroids -, by End Users USD Million (2016-2021)
  • Table 134. Africa Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 135. Africa Steroids -, by Species Types USD Million (2016-2021)
  • Table 136. North America Steroids -, by Country USD Million (2016-2021)
  • Table 137. North America Steroids -, by Type USD Million (2016-2021)
  • Table 138. North America Steroids -, by Application USD Million (2016-2021)
  • Table 139. North America Steroids -, by End Users USD Million (2016-2021)
  • Table 140. North America Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 141. North America Steroids -, by Species Types USD Million (2016-2021)
  • Table 142. United States Steroids -, by Type USD Million (2016-2021)
  • Table 143. United States Steroids -, by Application USD Million (2016-2021)
  • Table 144. United States Steroids -, by End Users USD Million (2016-2021)
  • Table 145. United States Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 146. United States Steroids -, by Species Types USD Million (2016-2021)
  • Table 147. Canada Steroids -, by Type USD Million (2016-2021)
  • Table 148. Canada Steroids -, by Application USD Million (2016-2021)
  • Table 149. Canada Steroids -, by End Users USD Million (2016-2021)
  • Table 150. Canada Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 151. Canada Steroids -, by Species Types USD Million (2016-2021)
  • Table 152. Mexico Steroids -, by Type USD Million (2016-2021)
  • Table 153. Mexico Steroids -, by Application USD Million (2016-2021)
  • Table 154. Mexico Steroids -, by End Users USD Million (2016-2021)
  • Table 155. Mexico Steroids -, by Distribution Channel USD Million (2016-2021)
  • Table 156. Mexico Steroids -, by Species Types USD Million (2016-2021)
  • Table 157. Steroids -: by Type(USD/Units)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Steroids -: by Type(USD Million)
  • Table 169. Steroids - Tablets , by Region USD Million (2022-2027)
  • Table 170. Steroids - Syrups , by Region USD Million (2022-2027)
  • Table 171. Steroids - Inhaler , by Region USD Million (2022-2027)
  • Table 172. Steroids - Nasal Spray , by Region USD Million (2022-2027)
  • Table 173. Steroids - Injection , by Region USD Million (2022-2027)
  • Table 174. Steroids - Cream/ Gel , by Region USD Million (2022-2027)
  • Table 175. Steroids -: by Application(USD Million)
  • Table 176. Steroids - Asthma , by Region USD Million (2022-2027)
  • Table 177. Steroids - Hay Fever , by Region USD Million (2022-2027)
  • Table 178. Steroids - Painful Joints or Muscles , by Region USD Million (2022-2027)
  • Table 179. Steroids - Chronic Obstructive Pulmonary Disease , by Region USD Million (2022-2027)
  • Table 180. Steroids - Inflammatory Bowel Disease , by Region USD Million (2022-2027)
  • Table 181. Steroids - Others , by Region USD Million (2022-2027)
  • Table 182. Steroids -: by End Users(USD Million)
  • Table 183. Steroids - Hospital , by Region USD Million (2022-2027)
  • Table 184. Steroids - Patient , by Region USD Million (2022-2027)
  • Table 185. Steroids - Body Builder , by Region USD Million (2022-2027)
  • Table 186. Steroids - Gymnastics , by Region USD Million (2022-2027)
  • Table 187. Steroids - Others , by Region USD Million (2022-2027)
  • Table 188. Steroids -: by Distribution Channel(USD Million)
  • Table 189. Steroids - Pharmacy , by Region USD Million (2022-2027)
  • Table 190. Steroids - Hospital , by Region USD Million (2022-2027)
  • Table 191. Steroids - Clinic , by Region USD Million (2022-2027)
  • Table 192. Steroids - Online , by Region USD Million (2022-2027)
  • Table 193. Steroids - Others , by Region USD Million (2022-2027)
  • Table 194. South America Steroids -, by Country USD Million (2022-2027)
  • Table 195. South America Steroids -, by Type USD Million (2022-2027)
  • Table 196. South America Steroids -, by Application USD Million (2022-2027)
  • Table 197. South America Steroids -, by End Users USD Million (2022-2027)
  • Table 198. South America Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 199. South America Steroids -, by Species Types USD Million (2022-2027)
  • Table 200. Brazil Steroids -, by Type USD Million (2022-2027)
  • Table 201. Brazil Steroids -, by Application USD Million (2022-2027)
  • Table 202. Brazil Steroids -, by End Users USD Million (2022-2027)
  • Table 203. Brazil Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 204. Brazil Steroids -, by Species Types USD Million (2022-2027)
  • Table 205. Argentina Steroids -, by Type USD Million (2022-2027)
  • Table 206. Argentina Steroids -, by Application USD Million (2022-2027)
  • Table 207. Argentina Steroids -, by End Users USD Million (2022-2027)
  • Table 208. Argentina Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 209. Argentina Steroids -, by Species Types USD Million (2022-2027)
  • Table 210. Rest of South America Steroids -, by Type USD Million (2022-2027)
  • Table 211. Rest of South America Steroids -, by Application USD Million (2022-2027)
  • Table 212. Rest of South America Steroids -, by End Users USD Million (2022-2027)
  • Table 213. Rest of South America Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 214. Rest of South America Steroids -, by Species Types USD Million (2022-2027)
  • Table 215. Asia Pacific Steroids -, by Country USD Million (2022-2027)
  • Table 216. Asia Pacific Steroids -, by Type USD Million (2022-2027)
  • Table 217. Asia Pacific Steroids -, by Application USD Million (2022-2027)
  • Table 218. Asia Pacific Steroids -, by End Users USD Million (2022-2027)
  • Table 219. Asia Pacific Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 220. Asia Pacific Steroids -, by Species Types USD Million (2022-2027)
  • Table 221. China Steroids -, by Type USD Million (2022-2027)
  • Table 222. China Steroids -, by Application USD Million (2022-2027)
  • Table 223. China Steroids -, by End Users USD Million (2022-2027)
  • Table 224. China Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 225. China Steroids -, by Species Types USD Million (2022-2027)
  • Table 226. Japan Steroids -, by Type USD Million (2022-2027)
  • Table 227. Japan Steroids -, by Application USD Million (2022-2027)
  • Table 228. Japan Steroids -, by End Users USD Million (2022-2027)
  • Table 229. Japan Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 230. Japan Steroids -, by Species Types USD Million (2022-2027)
  • Table 231. India Steroids -, by Type USD Million (2022-2027)
  • Table 232. India Steroids -, by Application USD Million (2022-2027)
  • Table 233. India Steroids -, by End Users USD Million (2022-2027)
  • Table 234. India Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 235. India Steroids -, by Species Types USD Million (2022-2027)
  • Table 236. South Korea Steroids -, by Type USD Million (2022-2027)
  • Table 237. South Korea Steroids -, by Application USD Million (2022-2027)
  • Table 238. South Korea Steroids -, by End Users USD Million (2022-2027)
  • Table 239. South Korea Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 240. South Korea Steroids -, by Species Types USD Million (2022-2027)
  • Table 241. Australia Steroids -, by Type USD Million (2022-2027)
  • Table 242. Australia Steroids -, by Application USD Million (2022-2027)
  • Table 243. Australia Steroids -, by End Users USD Million (2022-2027)
  • Table 244. Australia Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 245. Australia Steroids -, by Species Types USD Million (2022-2027)
  • Table 246. Rest of Asia-Pacific Steroids -, by Type USD Million (2022-2027)
  • Table 247. Rest of Asia-Pacific Steroids -, by Application USD Million (2022-2027)
  • Table 248. Rest of Asia-Pacific Steroids -, by End Users USD Million (2022-2027)
  • Table 249. Rest of Asia-Pacific Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 250. Rest of Asia-Pacific Steroids -, by Species Types USD Million (2022-2027)
  • Table 251. Europe Steroids -, by Country USD Million (2022-2027)
  • Table 252. Europe Steroids -, by Type USD Million (2022-2027)
  • Table 253. Europe Steroids -, by Application USD Million (2022-2027)
  • Table 254. Europe Steroids -, by End Users USD Million (2022-2027)
  • Table 255. Europe Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 256. Europe Steroids -, by Species Types USD Million (2022-2027)
  • Table 257. Germany Steroids -, by Type USD Million (2022-2027)
  • Table 258. Germany Steroids -, by Application USD Million (2022-2027)
  • Table 259. Germany Steroids -, by End Users USD Million (2022-2027)
  • Table 260. Germany Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 261. Germany Steroids -, by Species Types USD Million (2022-2027)
  • Table 262. France Steroids -, by Type USD Million (2022-2027)
  • Table 263. France Steroids -, by Application USD Million (2022-2027)
  • Table 264. France Steroids -, by End Users USD Million (2022-2027)
  • Table 265. France Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 266. France Steroids -, by Species Types USD Million (2022-2027)
  • Table 267. Italy Steroids -, by Type USD Million (2022-2027)
  • Table 268. Italy Steroids -, by Application USD Million (2022-2027)
  • Table 269. Italy Steroids -, by End Users USD Million (2022-2027)
  • Table 270. Italy Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 271. Italy Steroids -, by Species Types USD Million (2022-2027)
  • Table 272. United Kingdom Steroids -, by Type USD Million (2022-2027)
  • Table 273. United Kingdom Steroids -, by Application USD Million (2022-2027)
  • Table 274. United Kingdom Steroids -, by End Users USD Million (2022-2027)
  • Table 275. United Kingdom Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 276. United Kingdom Steroids -, by Species Types USD Million (2022-2027)
  • Table 277. Netherlands Steroids -, by Type USD Million (2022-2027)
  • Table 278. Netherlands Steroids -, by Application USD Million (2022-2027)
  • Table 279. Netherlands Steroids -, by End Users USD Million (2022-2027)
  • Table 280. Netherlands Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 281. Netherlands Steroids -, by Species Types USD Million (2022-2027)
  • Table 282. Rest of Europe Steroids -, by Type USD Million (2022-2027)
  • Table 283. Rest of Europe Steroids -, by Application USD Million (2022-2027)
  • Table 284. Rest of Europe Steroids -, by End Users USD Million (2022-2027)
  • Table 285. Rest of Europe Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 286. Rest of Europe Steroids -, by Species Types USD Million (2022-2027)
  • Table 287. MEA Steroids -, by Country USD Million (2022-2027)
  • Table 288. MEA Steroids -, by Type USD Million (2022-2027)
  • Table 289. MEA Steroids -, by Application USD Million (2022-2027)
  • Table 290. MEA Steroids -, by End Users USD Million (2022-2027)
  • Table 291. MEA Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 292. MEA Steroids -, by Species Types USD Million (2022-2027)
  • Table 293. Middle East Steroids -, by Type USD Million (2022-2027)
  • Table 294. Middle East Steroids -, by Application USD Million (2022-2027)
  • Table 295. Middle East Steroids -, by End Users USD Million (2022-2027)
  • Table 296. Middle East Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 297. Middle East Steroids -, by Species Types USD Million (2022-2027)
  • Table 298. Africa Steroids -, by Type USD Million (2022-2027)
  • Table 299. Africa Steroids -, by Application USD Million (2022-2027)
  • Table 300. Africa Steroids -, by End Users USD Million (2022-2027)
  • Table 301. Africa Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 302. Africa Steroids -, by Species Types USD Million (2022-2027)
  • Table 303. North America Steroids -, by Country USD Million (2022-2027)
  • Table 304. North America Steroids -, by Type USD Million (2022-2027)
  • Table 305. North America Steroids -, by Application USD Million (2022-2027)
  • Table 306. North America Steroids -, by End Users USD Million (2022-2027)
  • Table 307. North America Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 308. North America Steroids -, by Species Types USD Million (2022-2027)
  • Table 309. United States Steroids -, by Type USD Million (2022-2027)
  • Table 310. United States Steroids -, by Application USD Million (2022-2027)
  • Table 311. United States Steroids -, by End Users USD Million (2022-2027)
  • Table 312. United States Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 313. United States Steroids -, by Species Types USD Million (2022-2027)
  • Table 314. Canada Steroids -, by Type USD Million (2022-2027)
  • Table 315. Canada Steroids -, by Application USD Million (2022-2027)
  • Table 316. Canada Steroids -, by End Users USD Million (2022-2027)
  • Table 317. Canada Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 318. Canada Steroids -, by Species Types USD Million (2022-2027)
  • Table 319. Mexico Steroids -, by Type USD Million (2022-2027)
  • Table 320. Mexico Steroids -, by Application USD Million (2022-2027)
  • Table 321. Mexico Steroids -, by End Users USD Million (2022-2027)
  • Table 322. Mexico Steroids -, by Distribution Channel USD Million (2022-2027)
  • Table 323. Mexico Steroids -, by Species Types USD Million (2022-2027)
  • Table 324. Steroids -: by Type(USD/Units)
  • Table 325. Research Programs/Design for This Report
  • Table 326. Key Data Information from Secondary Sources
  • Table 327. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Steroids -: by Type USD Million (2016-2021)
  • Figure 5. Global Steroids -: by Application USD Million (2016-2021)
  • Figure 6. Global Steroids -: by End Users USD Million (2016-2021)
  • Figure 7. Global Steroids -: by Distribution Channel USD Million (2016-2021)
  • Figure 8. South America Steroids - Share (%), by Country
  • Figure 9. Asia Pacific Steroids - Share (%), by Country
  • Figure 10. Europe Steroids - Share (%), by Country
  • Figure 11. MEA Steroids - Share (%), by Country
  • Figure 12. North America Steroids - Share (%), by Country
  • Figure 13. Global Steroids -: by Type USD/Units (2016-2021)
  • Figure 14. Global Steroids - share by Players 2021 (%)
  • Figure 15. Global Steroids - share by Players (Top 3) 2021(%)
  • Figure 16. Global Steroids - share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer (United States) Revenue: by Geography 2021
  • Figure 20. Sanofi-Aventis (France) Revenue, Net Income and Gross profit
  • Figure 21. Sanofi-Aventis (France) Revenue: by Geography 2021
  • Figure 22. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2021
  • Figure 24. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. Novartis (Switzerland) Revenue: by Geography 2021
  • Figure 26. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. AstraZeneca (United Kingdom) Revenue: by Geography 2021
  • Figure 28. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 29. Merck (United States) Revenue: by Geography 2021
  • Figure 30. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 31. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 32. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Roche (Switzerland) Revenue: by Geography 2021
  • Figure 34. Eli Lilly & Co (United States) Revenue, Net Income and Gross profit
  • Figure 35. Eli Lilly & Co (United States) Revenue: by Geography 2021
  • Figure 36. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 37. Bristol-Myers Squibb (United States) Revenue: by Geography 2021
  • Figure 38. Global Steroids -: by Type USD Million (2022-2027)
  • Figure 39. Global Steroids -: by Application USD Million (2022-2027)
  • Figure 40. Global Steroids -: by End Users USD Million (2022-2027)
  • Figure 41. Global Steroids -: by Distribution Channel USD Million (2022-2027)
  • Figure 42. South America Steroids - Share (%), by Country
  • Figure 43. Asia Pacific Steroids - Share (%), by Country
  • Figure 44. Europe Steroids - Share (%), by Country
  • Figure 45. MEA Steroids - Share (%), by Country
  • Figure 46. North America Steroids - Share (%), by Country
  • Figure 47. Global Steroids -: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Sanofi-Aventis (France)
  • GlaxoSmithKline (United Kingdom)
  • Novartis (Switzerland)
  • AstraZeneca (United Kingdom)
  • Merck (United States)
  • Johnson & Johnson (United States)
  • Roche (Switzerland)
  • Eli Lilly & Co (United States)
  • Bristol-Myers Squibb (United States)
Additional players considered in the study are as follows:
Wyeth (United States) , Schering-Plough (United States) , Abbott Laboratories (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 222 Pages 87 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Steroids - Market Quantitative research analysis
Global Steroids - Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Pfizer (United States), Sanofi-Aventis (France), GlaxoSmithKline (United Kingdom), Novartis (Switzerland), AstraZeneca (United Kingdom), Merck (United States), Johnson & Johnson (United States), Roche (Switzerland), Eli Lilly & Co (United States) and Bristol-Myers Squibb (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"High Adoption of Steroid in Body Building Sector " is seen as one of major influencing trends for Steroids - Market during projected period 2021-2027.
The Steroids - market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Steroids - Market Report?

Have a Query? Click Here

Other Related Reports

Recycled Plastic Tiles Comprehensive Study by Type (Polyethylene, Polyethylene Terephthalate, Polypropylene, Polyvinyl Chloride, Polystyrene, Others), Application (Industrial Purpose, Construction, D...
$ 3800
Chemical Control System Comprehensive Study by Type (Pesticides, Herbicides, Bactericides, Fungicides), Application (Agricultural, Industrial, Other), Service (Filtration, Installation, Construction,...
$ 3800
High end Cosmetic Comprehensive Study by Type (Skin Care, Hair Care, Make-Up, Others), Application (Female, Male, Others), Raw Materials (Functional, Aesthetic Modifier, Claims), Distribution Channel...
$ 3800
Propylene-Petrochemical Comprehensive Study by Type (Homopolymer, Copolymer), Application (Injection Molding, Fiber and Raffia, Film and Sheet, Blow Molding), Technology (Fiber Steam Cracking, Refine...
$ 3800
Building Maintenance Chemicals Comprehensive Study by Type (Concrete Admixtures, Waterproofing Chemicals, Flooring Compounds, Adhesives, Caulks and Sealants, Other), Application (Floor Care, Windows ...
$ 3800
Spray Polyurethane Foam (SPF) Roofing Systems Comprehensive Study by Application (Commercial Buildings, Industrial Buildings, Residential Buildings), Material (Isocyanate, Polyol), Solution (Insulati...
$ 3800